Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study to investigate how budesonide and formoterol behave in the body when delivered with different inhaler devices in children aged 4…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)
  • Formoterol (formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: RECRUITING